Upconverted/Downshifted NaLnF 4 and Metal-Organic Framework Heterostructures Boosting NIR-II Imaging-Guided Photodynamic Immunotherapy Toward Tumors

Qi-Xian Wang,Yuan-Fan Yang,Xiang-Fei Yang,Yue Pan,Ling-Dong Sun,Wen-Yuan Zhang,Yulei Shao,Jie Shen,Jian Lin,Lele Li,Chun-Hua Yan

DOI: https://doi.org/10.2139/ssrn.4005788

2022-01-01

Abstract:Heterostructures of NaLnF4 and porphyrinic metal-organic frameworks (MOF) have been reported as a promising platform for near-infrared (NIR)-driven photodynamic therapy (PDT), while the energy transfer from NaLnF4 to MOF greatly decreased the upconversion emissions. To develop NaLnF4 and MOF heterostructure s with significantly improved PDT and imaging simultaneously is important to track their location to implement therapy accurately. Herein, we constructed Er3+-doped NaLnF4@MOF core@shell nanoparticles to integrate NIR-driven PDT and NIR-II imaging. NaLnF4 nanoparticles are designed with upconversion and NIR emission simultaneously under a single 980 nm excitation, where the upconversion luminescence (UCL) overlaps well with the absorption of Zr-based porphyrin MOF, enabling efficient energy transfer from NaLnF4 to the MOF shell to generate 1O2. And the NIR luminescence, which gave out under a lower excitation power than that of UCL, could be used to track the location and distribution of the heterostructures via NIR-II imaging. Moreover, antiprogrammed death-ligand 1 (α-PD-L1) immunotherapy was introduced synergistically to improve antitumor immunity efficacy. The combination of NaLnF4@MOF and α-PD-L1 not only inhibited primary tumors but also suppressed distant one, leading to an effective tumor inhibition rate of 95%. This work provides an integrated nanoplatform boosting NIR-II imaging-guided PDT/ immunotherapy efficacy for tumor treatment.